Hou Xu, Jiang Xiaohong, Zhang Wei, Liu Jun
Department of Hepatobiliary Surgery, Liaocheng People's Hospital/Affiliated to Shandong University/Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences/Affiliated to Shandong Second Medical University, No. 67 Dongchang West Road, Liaocheng, 25200, Shandong, China.
Zhong Yuan Academy of Biological Medicine, Liaocheng People's Hospital, No. 67 Dongchang West Road, Liaocheng, 252000, Shandong, China.
Discov Oncol. 2025 Feb 20;16(1):213. doi: 10.1007/s12672-025-01977-7.
This study analyzes the research landscape of nanomaterials in treating hepatocellular carcinoma (HCC) and examines publication trends in this field by conducting a comprehensive bibliometric analysis within the Web of Science Core Collection (WoSCC) database. Articles published from 2000 to September 16, 2024 were retrieved using a structured search formula targeting studies on nanomaterials in HCC, including nanoparticles, nanodots, nanorods, nanosheets, and nanomedicine. Only English full-text articles and reviews relevant to nanomaterial applications in HCC were considered, excluding conference abstracts and non-research items. The analysis encompasses annual publication trends, country-wise publication distribution, prominent institutions, and key journals in the field. Statistical and graphical analyses were performed using GraphPad Prism (v8.0.2) to illustrate publication trends. CiteSpace (6.2.4R) and VOSviewer (1.6.18) software were used to visualize co-citation and keyword networks, highlighting scientific knowledge structures and research hotspots. Notable advancements have emerged as a promising strategy, enabling hepatocyte-specific drug delivery to enhance therapeutic precision and minimize off-target effects. This analysis provides a comprehensive understanding of the evolution of HCC nanomaterials research, key contributing countries, major research institutions, and frequently cited keywords. The findings offer valuable insights into the field's knowledge base, emerging trends, and future directions in HCC treatment with nanomaterials.
本研究分析了纳米材料在治疗肝细胞癌(HCC)方面的研究概况,并通过在科学网核心合集(WoSCC)数据库中进行全面的文献计量分析,考察了该领域的出版趋势。使用针对HCC中纳米材料研究的结构化检索公式,检索了2000年至2024年9月16日发表的文章,包括纳米颗粒、纳米点、纳米棒、纳米片和纳米医学。仅考虑与纳米材料在HCC中的应用相关的英文全文文章和综述,排除会议摘要和非研究项目。分析涵盖年度出版趋势、国家层面的出版分布、知名机构以及该领域的关键期刊。使用GraphPad Prism(v8.0.2)进行统计和图形分析,以说明出版趋势。使用CiteSpace(6.2.4R)和VOSviewer(1.6.18)软件可视化共被引和关键词网络,突出科学知识结构和研究热点。显著进展已成为一种有前景的策略,能够实现肝细胞特异性药物递送,以提高治疗精准度并最小化脱靶效应。本分析全面了解了HCC纳米材料研究的演变、主要贡献国家、主要研究机构以及频繁被引用的关键词。研究结果为该领域的知识库、新兴趋势以及纳米材料治疗HCC的未来方向提供了有价值的见解。